Which finding would indicate a therapeutic response in a client taking risperidone?

A therapeutic response in a client taking risperidone is indicated by a decrease in symptoms associated with psychotic disorders, such as paranoia or delusions. The drug is an atypical antipsychotic that primarily works by blocking dopamine receptors in the brain, which can help reduce delusional thoughts and improve overall mental clarity.

When patients experience decreased thoughts of persecution, it implies that the medication is effectively addressing symptoms of paranoia, which is a common manifestation in conditions like schizophrenia or severe bipolar disorder. This reduction in paranoia is a positive sign that the medication is working as intended.

In contrast, other options do not align with the primary objectives of risperidone therapy. While weight change can occur during treatment, it is not a direct indicator of therapeutic efficacy related to the symptoms the medication is meant to treat. Increased mood lability suggests instability in mood, which may signal that the treatment is inadequate or that the patient's condition is not being effectively managed. An appropriate gait pattern might be a sign of overall physical health or coordination but does not directly correlate with the therapeutic goals for psychotic symptoms.